메뉴 건너뛰기




Volumn 4, Issue 2, 2012, Pages 98-102

Evolution of the concept of treatment-resistant schizophrenia: Toward a reformulation for lack of an adequate response

Author keywords

Antipsychotic drugs; Clozapine; Treatment for schizophrenia; Treatment refractory schizophrenia; Treatment resistant schizophrenia

Indexed keywords

CHLORPROMAZINE; NEUROLEPTIC AGENT;

EID: 84859589418     PISSN: 18783317     EISSN: 18783325     Source Type: Journal    
DOI: 10.1016/j.jecm.2012.02.003     Document Type: Review
Times cited : (12)

References (39)
  • 1
    • 22144432283 scopus 로고    scopus 로고
    • A systematic review of the prevalence of schizophrenia
    • Saha S., Chant D., Welham J., McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med 2005, 2:e141.
    • (2005) PLoS Med , vol.2
    • Saha, S.1    Chant, D.2    Welham, J.3    McGrath, J.4
  • 2
    • 0031417026 scopus 로고    scopus 로고
    • Treatment-resistant schizophrenia: the role of clozapine
    • Meltzer H.Y. Treatment-resistant schizophrenia: the role of clozapine. Curr Med Res Opin 1997, 14:1-20.
    • (1997) Curr Med Res Opin , vol.14 , pp. 1-20
    • Meltzer, H.Y.1
  • 3
    • 0032073383 scopus 로고    scopus 로고
    • The natural history and pathophysiology of treatment resistant schizophrenia
    • Sheitman B.B., Lieberman J.A. The natural history and pathophysiology of treatment resistant schizophrenia. J Psychiatr Res 1998, 2:143-150.
    • (1998) J Psychiatr Res , vol.2 , pp. 143-150
    • Sheitman, B.B.1    Lieberman, J.A.2
  • 4
    • 0023812652 scopus 로고
    • Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine
    • Kane J., Honigfeld G., Singer J., Meltzer H. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988, 45:789-796.
    • (1988) Arch Gen Psychiatry , vol.45 , pp. 789-796
    • Kane, J.1    Honigfeld, G.2    Singer, J.3    Meltzer, H.4
  • 6
    • 0029896051 scopus 로고    scopus 로고
    • Proper psychosocial rehabilitation for stabilised patients with schizophrenia: the role of new therapies
    • Peuskens J. Proper psychosocial rehabilitation for stabilised patients with schizophrenia: the role of new therapies. Eur Neuropsychopharmacol 1996, 6:S7-12.
    • (1996) Eur Neuropsychopharmacol , vol.6
    • Peuskens, J.1
  • 7
    • 0035666578 scopus 로고    scopus 로고
    • The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches
    • Lieberman J.A., Perkins D., Belger A., Chakos M., Jarskog F., Boteva K., Gilmore J. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry 2001, 50:884-897.
    • (2001) Biol Psychiatry , vol.50 , pp. 884-897
    • Lieberman, J.A.1    Perkins, D.2    Belger, A.3    Chakos, M.4    Jarskog, F.5    Boteva, K.6    Gilmore, J.7
  • 8
    • 33845651345 scopus 로고    scopus 로고
    • Remission in first-episode psychosis: predictor variables and symptom improvement patterns
    • Emsley R., Oosthuizen P.P., Kidd M., Koen L., Niehaus D.J., Turner H.J. Remission in first-episode psychosis: predictor variables and symptom improvement patterns. J Clin Psychiatry 2006, 67:1707-1712.
    • (2006) J Clin Psychiatry , vol.67 , pp. 1707-1712
    • Emsley, R.1    Oosthuizen, P.P.2    Kidd, M.3    Koen, L.4    Niehaus, D.J.5    Turner, H.J.6
  • 9
    • 0032852650 scopus 로고    scopus 로고
    • Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?
    • McGlashan T.H. Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?. Biol Psychiatry 1999, 46:899-907.
    • (1999) Biol Psychiatry , vol.46 , pp. 899-907
    • McGlashan, T.H.1
  • 12
    • 0035667156 scopus 로고    scopus 로고
    • Management of treatment resistance in schizophrenia
    • Conley R.R., Kelly D.R. Management of treatment resistance in schizophrenia. Biol Psychiatry 2001, 50:898-911.
    • (2001) Biol Psychiatry , vol.50 , pp. 898-911
    • Conley, R.R.1    Kelly, D.R.2
  • 13
    • 0000187287 scopus 로고
    • Treatment-resistant schizophrenia
    • Blackwell Science Ltd., Oxford, S.R. Hirsch (Ed.)
    • Schultz S.C. Treatment-resistant schizophrenia. Schizophrenia 1995, 484-496. Blackwell Science Ltd., Oxford. S.R. Hirsch (Ed.).
    • (1995) Schizophrenia , pp. 484-496
    • Schultz, S.C.1
  • 14
    • 33645033116 scopus 로고    scopus 로고
    • Esquizofrenia resistente al tratamiento farmacológico
    • Cervera Enguix S., Seva Fernandez A. Esquizofrenia resistente al tratamiento farmacológico. Actas Esp Psiquiatr 2006, 34:48-54.
    • (2006) Actas Esp Psiquiatr , vol.34 , pp. 48-54
    • Cervera Enguix, S.1    Seva Fernandez, A.2
  • 15
    • 0018865788 scopus 로고
    • Parenteral loxapine in severely disturbed schizophrenic patients
    • Deniker P., Loo H., Cottereau M.J. Parenteral loxapine in severely disturbed schizophrenic patients. J Clin Psychiatry 1980, 41:23-26.
    • (1980) J Clin Psychiatry , vol.41 , pp. 23-26
    • Deniker, P.1    Loo, H.2    Cottereau, M.J.3
  • 16
    • 0033017831 scopus 로고    scopus 로고
    • The evolving definition of Treatment Resistance
    • Peuskens J. The evolving definition of Treatment Resistance. J Clin Psychiatry 1999, 60:4-8.
    • (1999) J Clin Psychiatry , vol.60 , pp. 4-8
    • Peuskens, J.1
  • 17
    • 0027178496 scopus 로고
    • Psychopharmacologic treatment of schizophrenia
    • Kane J., Marder S.R. Psychopharmacologic treatment of schizophrenia. Schizophr Bull 1993, 19:287-302.
    • (1993) Schizophr Bull , vol.19 , pp. 287-302
    • Kane, J.1    Marder, S.R.2
  • 19
    • 0029989771 scopus 로고    scopus 로고
    • Pharmacological treatment strategies in the non-responsive schizophrenic patient
    • Barnes T.R., McEvedy C.J. Pharmacological treatment strategies in the non-responsive schizophrenic patient. Int Clin Psychopharmacol 1996, 11:67-71.
    • (1996) Int Clin Psychopharmacol , vol.11 , pp. 67-71
    • Barnes, T.R.1    McEvedy, C.J.2
  • 20
    • 0026718710 scopus 로고
    • Positron emission tomographic analysis of central D1 and D2 dopamine receptors occupancy in patient treated with classical neuroleptic and clozapine: relation to extrapyramidal side effects
    • Fabre L.F., Nordström A.L., Wiesel F.A., Pauli S., Halldin C., Sedvall G. Positron emission tomographic analysis of central D1 and D2 dopamine receptors occupancy in patient treated with classical neuroleptic and clozapine: relation to extrapyramidal side effects. Arch Gen Psychiatry 1992, 49:538-544.
    • (1992) Arch Gen Psychiatry , vol.49 , pp. 538-544
    • Fabre, L.F.1    Nordström, A.L.2    Wiesel, F.A.3    Pauli, S.4    Halldin, C.5    Sedvall, G.6
  • 23
    • 0026796022 scopus 로고
    • Treatment of the neuroleptic-nonresponsive schizophrenic patient
    • Meltzer H.Y. Treatment of the neuroleptic-nonresponsive schizophrenic patient. Schizophr Bull 1992, 18:515-542.
    • (1992) Schizophr Bull , vol.18 , pp. 515-542
    • Meltzer, H.Y.1
  • 24
    • 0026517979 scopus 로고
    • Dimensions of outcome with clozapine
    • Meltzer H.Y. Dimensions of outcome with clozapine. Br J Psychiatry 1992, 160:46-53.
    • (1992) Br J Psychiatry , vol.160 , pp. 46-53
    • Meltzer, H.Y.1
  • 26
    • 0003174188 scopus 로고    scopus 로고
    • Practice guideline for the treatment of patients with schizophrenia
    • American Psychiatric Association
    • Practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry 1997, 154:1-63. American Psychiatric Association.
    • (1997) Am J Psychiatry , vol.154 , pp. 1-63
  • 27
    • 2842615828 scopus 로고    scopus 로고
    • Estudio crítico de la influencia de los síntomas negativos en la respuesta terapeútica de la esquizofrenia
    • Acuña M.J., Martin J., Noval D., Blanco M. Estudio crítico de la influencia de los síntomas negativos en la respuesta terapeútica de la esquizofrenia. Actas Luso Esp Neurol Psiquiatr Cienc Afines 1998, 26:209-213.
    • (1998) Actas Luso Esp Neurol Psiquiatr Cienc Afines , vol.26 , pp. 209-213
    • Acuña, M.J.1    Martin, J.2    Noval, D.3    Blanco, M.4
  • 28
    • 0027414570 scopus 로고
    • Negative symptoms and emotional blunting in schizophrenic patients
    • De Leon J., Peralta V., Cuesta M. Negative symptoms and emotional blunting in schizophrenic patients. J Clin Psychiatry 1993, 54:103-108.
    • (1993) J Clin Psychiatry , vol.54 , pp. 103-108
    • De Leon, J.1    Peralta, V.2    Cuesta, M.3
  • 29
    • 0018899460 scopus 로고
    • Molecular pathology of schizophrenia: more than one disease process?
    • Crow T.J. Molecular pathology of schizophrenia: more than one disease process?. Br Med J 1980, 280:66-68.
    • (1980) Br Med J , vol.280 , pp. 66-68
    • Crow, T.J.1
  • 32
    • 0021877999 scopus 로고
    • Negative symptoms in schizophrenia: their longitudinal course and prognostic importance
    • Pogue-Geile M.F., Harrow M. Negative symptoms in schizophrenia: their longitudinal course and prognostic importance. Am J Psychiatry 1985, 11:427-439.
    • (1985) Am J Psychiatry , vol.11 , pp. 427-439
    • Pogue-Geile, M.F.1    Harrow, M.2
  • 33
    • 0023883767 scopus 로고
    • Deficit and nondeficit forms of schizophrenia: the concept
    • Carpenter W.T. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 1988, 145:578-583.
    • (1988) Am J Psychiatry , vol.145 , pp. 578-583
    • Carpenter, W.T.1
  • 34
    • 0027944883 scopus 로고
    • An empirical analysis of latent structures underlying schizophrenic symptoms: a four-syndrome model
    • Peralta V., Cuesta M., De Leon J. An empirical analysis of latent structures underlying schizophrenic symptoms: a four-syndrome model. Biol Psychiatry 1994, 36:726-736.
    • (1994) Biol Psychiatry , vol.36 , pp. 726-736
    • Peralta, V.1    Cuesta, M.2    De Leon, J.3
  • 35
    • 47249104675 scopus 로고    scopus 로고
    • The evolution of drug development in schizophrenia: past issues and future opportunities
    • Carpenter W.T., Koenig J.I. The evolution of drug development in schizophrenia: past issues and future opportunities. Neuropsychopharmacology 2008, 33:2061-2079.
    • (2008) Neuropsychopharmacology , vol.33 , pp. 2061-2079
    • Carpenter, W.T.1    Koenig, J.I.2
  • 37
    • 34447102638 scopus 로고    scopus 로고
    • Sustained remission in schizophrenia
    • Liberman R.P., Kopelowicz A. Sustained remission in schizophrenia. Am J Psychiatry 2005, 162:1763.
    • (2005) Am J Psychiatry , vol.162 , pp. 1763
    • Liberman, R.P.1    Kopelowicz, A.2
  • 38
    • 85012092311 scopus 로고    scopus 로고
    • Early intervention in psychosis. The critical period hypothesis
    • Birchwood M., Todd P., Jackson C. Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry 1998, 172:53-59.
    • (1998) Br J Psychiatry , vol.172 , pp. 53-59
    • Birchwood, M.1    Todd, P.2    Jackson, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.